Φιλτράρισμα ανά Last updated date SelectΜετάΠρινFrom - To Date Ημερομηνία λήξης This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Αποτελέσματα (3839) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank New co-chairs elected for working parties for healthcare professionals and for patients and consumers 23 Σεπτέμβριος 2022NewsCorporate Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 September 2022 22 Σεπτέμβριος 2022NewsHumanCOVID-19Medicines Biosimilar medicines can be interchanged 19 Σεπτέμβριος 2022NewsHumanCorporateBiosimilars New medicine to protect babies and infants from respiratory syncytial virus (RSV) infection 16 Σεπτέμβριος 2022NewsHumanMedicines EMA recommends standard marketing authorisations for Comirnaty and Spikevax COVID-19 vaccines 16 Σεπτέμβριος 2022NewsHumanCOVID-19Vaccines Adapted vaccine targeting BA.4 and BA.5 Omicron variants and original SARS-CoV-2 recommended for approval 12 Σεπτέμβριος 2022NewsHumanCOVID-19Vaccines Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 6-8 September 2022 9 Σεπτέμβριος 2022NewsVeterinaryMedicines ECDC-EMA statement on booster vaccination with Omicron adapted bivalent COVID-19 vaccines 6 Σεπτέμβριος 2022NewsHumanCOVID-19Vaccines Accelerating Clinical Trials in the EU: publication of 2022-2026 workplan 2 Σεπτέμβριος 2022NewsHumanClinical trials Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 29 August – 1 September 2022 2 Σεπτέμβριος 2022NewsHumanPharmacovigilanceReferrals 1 … 40 41 42 43 44 Page 44 of 384 45 46 47 48 … 384
New co-chairs elected for working parties for healthcare professionals and for patients and consumers 23 Σεπτέμβριος 2022NewsCorporate
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 September 2022 22 Σεπτέμβριος 2022NewsHumanCOVID-19Medicines
New medicine to protect babies and infants from respiratory syncytial virus (RSV) infection 16 Σεπτέμβριος 2022NewsHumanMedicines
EMA recommends standard marketing authorisations for Comirnaty and Spikevax COVID-19 vaccines 16 Σεπτέμβριος 2022NewsHumanCOVID-19Vaccines
Adapted vaccine targeting BA.4 and BA.5 Omicron variants and original SARS-CoV-2 recommended for approval 12 Σεπτέμβριος 2022NewsHumanCOVID-19Vaccines
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 6-8 September 2022 9 Σεπτέμβριος 2022NewsVeterinaryMedicines
ECDC-EMA statement on booster vaccination with Omicron adapted bivalent COVID-19 vaccines 6 Σεπτέμβριος 2022NewsHumanCOVID-19Vaccines
Accelerating Clinical Trials in the EU: publication of 2022-2026 workplan 2 Σεπτέμβριος 2022NewsHumanClinical trials
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 29 August – 1 September 2022 2 Σεπτέμβριος 2022NewsHumanPharmacovigilanceReferrals